For investors
Norway loses NOK 59 billion a year to poor women's occupational health. Menoa is building the solution.
Menoa is building a B2B platform that helps businesses support employees through menopause. A large, untapped market with strong regulatory tailwinds and documented need.
The problem at work
An invisible problem in the workplace
Menopause hits mid-career. Yet few businesses have any measures in place, and many women face the symptoms alone. The cost: absenteeism, turnover and lost expertise.
0 in 3
women experience significant symptoms that affect daily life, ability to work and quality of life
0+
symptoms are linked to menopause
0%
of women lack good information about their own health
Research and documentation
Documented need
Menoa is built on a solid knowledge base. Here is some of the research that drives us.
KLAR studyOne in three women experience significant health problems during menopause that affect daily life.
Research reportMenopause can lead to income loss and reduced attachment to the labor market for women mid-career.
Women's Health StrategyThe government will strengthen knowledge about women's health and ensure equitable health services for women in all life stages.
Sources and knowledge base
Market opportunity
A large, untapped market
FemTech is one of the fastest-growing categories in health technology. Yet menopause has barely been addressed in the workplace.
0
Norwegian women enter menopause every year. About 9,000 experience significant symptoms that affect their ability to work and quality of life.
0 mrd kr
annual societal costs in Norway from poor women's occupational health
0 mrd USD
global annual GDP loss from menopause
Growth staircase
From Norwegian base to European reach
Each step unlocks a substantially larger share of the market.
Launch
Norway
240,000 women 40+ at companies with 50+ employees.
~NOK 570M
Expansion
Nordics
SE, DK, FI, IS, NO. ~1.65M women 40+ in the target group.
~NOK 3.9bn
Scale
Europe
EU-27 + UK + Norway + Switzerland. ~20.5M women 40+ in the target group.
~NOK 49bn
Bottom-up SAM at NOK 2,388 ARR per woman 40+. Population from Eurostat LFSA_EGAN, firm-size filter from Eurostat SBS 2023 (51.2% of employment in firms with 50+ employees). Share of women 40-59 is interpolated from Eurostat's age bands.
Norwegian B2B SAM (bottom-up)
5% penetration: Norway ~NOK 29M, Nordics ~NOK 195M, Europe ~NOK 2.5bn ARR.
Why now
Four tailwinds that make the timing right
Four tailwinds that make the timing right
National Women's Health Strategy
The Norwegian government has launched a national strategy to strengthen women's health. Menopause is explicitly mentioned as a priority area.
ESG and diversity
Companies face increasing requirements for reporting on diversity, wellbeing and sustainable working life. Support during menopause is a concrete measure.
The FemTech wave
Over $1.2 billion invested in FemTech globally in 2024. Women's health is one of the fastest-growing categories in health technology.
Public attention
Media coverage of menopause in the workplace has exploded. The topic is no longer taboo, but the solutions are missing.
The product
From daily tracking to concrete guidance
Menoa combines daily symptom tracking, personal insight and an AI-powered coach, so women can take control of their own health and employers can offer real support.
Step 01
Daily check-in
Log sleep, energy, mood and symptoms in under 30 seconds. Over time, patterns and connections become visible.
- Sleep, energy and mood on a 5-point scale
- 45+ selectable symptoms
- Under 30 seconds per day
I dag
Daglig check-in
Symptomer
Step 02
Personal insights
Menoa detects patterns in your logs. Poor sleep several days in a row? Symptoms that appear together? You get simple, understandable summaries.
- Weekly wellbeing score based on your data
- Automatic pattern detection
- Explanations in plain text, not graphs
Siste 7 dager
Din innsikt
Du har hatt lav energi 4 av 7 dager. Det sammenfaller med dårlig søvn.
Step 03
Favn
A supportive conversation partner that knows your symptoms and logs. Ask questions, get explanations and concrete advice tailored to your situation.
- Understands your logs and patterns
- Concrete actions, not generic advice
- Available when you need it
Menoa-coach
Basert på dine registreringer
Jeg sover så dårlig for tiden. Er det vanlig?
Ja, søvnproblemer er et av de vanligste symptomene. De siste 5 dagene har du logget dårlig søvn. Noen ting som kan hjelpe:
- Unngå skjerm siste time før sengetid
- Hold soverommet kjølig
Snakk med legen din om plagene vedvarer.
Step 04
Report for your doctor
Collect symptoms, patterns and summaries in a report you can bring to your doctor. Makes it easier to explain what you're experiencing.
- 3-month summary in one document
- Top symptoms with frequency and intensity
- Download as PDF or share digitally
Eksporter
Rapport til lege
3 mnd oppsummering
Privacy and data security
Health data is especially sensitive. Menoa is built with GDPR Article 9 as its foundation: encrypted storage (AES-256), explicit consent per purpose, and full rights to access, export and deletion. HR sees only anonymized aggregates, never individual data.
Pricing and partner model
Simple pricing, no surprises
Menoa Standard
Full Menoa for all female employees aged 40 and older. Minimum 20 women. Billed annually.
- Menoa app for all women 40+
- HR dashboard with anonymized trends (5-user threshold)
- PDF reports for the board and ESG export
- SSO with Microsoft Entra ID included
- Dedicated contact person
Foundational Partner
Limited to our first five customers3-mo pilot · optional 12-mo extension · half price
3-month half-price pilot from day 1. After the evaluation you can extend at half price for 12 months. Standard price is NOK 199 per woman 40+ per month. Limited to five partners.
- 3-month pilot: NOK 99 per woman 40+ per month
- Optional extension: 12 months at half price
- Full evaluation report after month 3
- Logo rights in Menoa's marketing from day 1
- Joint case study upon extension
- Quarterly reference calls during the extension period
Union federation or more than 1,000 women 40+? Contact us for a custom setup: hei@menoa.no
Competitive landscape
Peppy, Maven and Elektra have proven the market internationally. No one owns the Nordics.
Internationally, there are established players selling menopause support to employers. In Norway and the Nordics, the field is empty. Menoa is building for the Norwegian workplace from day one.
No Nordic player combines menopause specialization with a B2B model
Our competitive advantage
Why Menoa wins in the Norwegian market
Global players can't simply translate their product and land in Norway. The Norwegian requirements for language, labor law and data storage are built into Menoa from day one.
Norwegian language and cultural context
The entire app, content, coach dialogues and HR reports are written in Norwegian by Norwegian health professionals. Peppy and Maven run in English.
NAV and the Working Environment Act built in
The HR dashboard and reporting are shaped by Norwegian sick leave rules, accommodation obligations and the IA agreement, not the UK Equality Act.
Data in EU/EEA, GDPR Art. 9 as foundation
Health data stored in EU/EEA, encrypted with AES-256. DPA ready and Entra ID SSO included. A must for public sector and regulated businesses.
Clinical grounding in Norwegian research
Built on the KLAR study (UiB), the Women's Health Strategy and NOU 2025:5. The content reflects Norwegian health standards and guidelines.
The team
Built by people who understand the problem
Lene Larsgård
CEO
Passionate about ensuring women are seen and supported in a phase of life that has been overlooked for too long. Experience as an elected politician with hands-on experience in policy development and measures to reduce sick leave. Master's in technology and innovation studies from the University of Oslo.
Håkon Kjelseth
Co-founder
Several years of experience as tech lead at DNV building enterprise systems at scale. Built the health app QuitNic, gaining practical experience with behavior change and health data. Placed 3rd solo in Norway's first AI championship with over 3,100 participants.
We're building an advisory team in gynecology, occupational health and health technology.
Roadmap
From development to Nordic expansion
Q2 2026
Product development
Build the first version of Menoa with core features: symptom tracking and personal insights.
Q3 2026
Pilot
Test with first pilot companies and early users. Improve based on feedback.
Q4 2026
Launch
Launch Menoa for the Norwegian market. B2B and B2C model in operation.
2027
Nordic expansion
Expand to Sweden, Denmark and Finland. Grow B2B sales and partnerships.
Invest in better women's health
We're seeking early-stage funding to build and launch Menoa. Get in touch to learn more about the opportunity.